EGFR mutations are significantly associated with visceral pleural invasion development in non-small-cell lung cancer patients

References

• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• TravisWDBrambillaERielyGJNew pathologic classification of lung cancer: relevance for clinical practice and clinical trialsJ Clin Oncol2013318992100123401443
   PubMed Web of Science ®Google Scholar
• DacicSShuaiYYousemSOhoriPNikiforovaMClinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomasMod Pathol201023215916819855375
   PubMed Web of Science ®Google Scholar
• YangSYYangTYChenKCEGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patientsClin Cancer Res20111782149215821300759
   PubMed Web of Science ®Google Scholar
• RenSKuangPZhengLAnalysis of driver mutations in female non-smoker Asian patients with pulmonary adenocarcinomaCell Biochem Biophys201264215516022707299
   PubMed Web of Science ®Google Scholar
• KeedyVLTeminSSomerfieldMRAmerican Society of clinical oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapyJ Clin Oncol201129152121212721482992
   PubMed Web of Science ®Google Scholar
• RenaudSSeitlingerJGuerreraFPrognostic value of exon 19 versus 21 EGFR mutations varies according to disease stage in surgically resected non-small cell lung cancer adenocarcinomaAnn Surg Oncol20182541069107829362963
   PubMed Web of Science ®Google Scholar
• TakamochiKOhSMatsunagaTSuzukiKPrognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinomaJ Thorac Cardiovasc Surg201715451768177428826599
   PubMed Web of Science ®Google Scholar
• LeeCKWuYLDingPNImpact of specific epidermal growth factor receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: a meta-analysisJ Clin Oncol201533171958196525897154
   PubMed Web of Science ®Google Scholar
• KuanFCKuoLTChenMCOverall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysisBr J Cancer2015113101519152826461059
   PubMed Web of Science ®Google Scholar
• BrewerLABaiAFLittleJNRabagoYPardoGCarcinoma of the lung; practical classification for early diagnosis and surgical treatmentJ Am Med Assoc1958166101149115513513332
   PubMed Web of Science ®Google Scholar
• LakhaSGomezJEFloresRMWisniveskyJPPrognostic significance of visceral pleural involvement in early-stage lung cancerChest201414661619162625032521
   PubMed Web of Science ®Google Scholar
• Rami-PortaRBolejackVCrowleyJThe IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancerJ Thorac Oncol2015107990100326134221
   PubMed Web of Science ®Google Scholar
• Manac’hDRiquetMMedioniJLe Pimpec-BarthesFDujonADanelCVisceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factorAnn Thorac Surg20017141088109311308141
   PubMed Web of Science ®Google Scholar
• ChangYLLinMWShihJYWuCTLeeYCThe significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retractionAnn Surg Oncol20121993057306422492226
   PubMed Web of Science ®Google Scholar
• TianDPeiYZhengQEffect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancerThorac Cancer2017829710528256095
   PubMed Web of Science ®Google Scholar
• EbaraKTakashimaSJiangBPleural invasion by peripheral lung cancer: prediction with three-dimensional CTAcad Radiol201522331031925542401
   PubMed Web of Science ®Google Scholar
• HsuJSHanITTsaiTHPleural tags on CT scans to predict visceral pleural invasion of non-small cell lung cancer that does not abut the pleuraRadiology2016279259059626653684
   PubMed Web of Science ®Google Scholar
• ZhangSMZhuQGDingXXPrognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysisCancer Manag Res2018103393340430237741
   PubMed Web of Science ®Google Scholar
• GlazerHSDuncan-MeyerJAronbergDJMoranJFLevittRGSagelSSPleural and chest wall invasion in bronchogenic carcinoma: CT evaluationRadiology198515711911944034965
   PubMed Web of Science ®Google Scholar
• NeriSYoshidaJIshiiGPrognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patientsAnn Surg2014260238338824646539
   PubMed Web of Science ®Google Scholar
• DavidEThallPFKalhorNVisceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor sizeAnn Thorac Surg20139561872187723643547
   PubMed Web of Science ®Google Scholar
• YanagawaNShionoSAbikoMOgataSYSatoTTamuraGPrognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinomaEur J Cardiothorac Surg2013443e200e20623766428
   PubMed Web of Science ®Google Scholar
• KimYTSeongYWJungYJThe presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancerJ Thorac Oncol20138217117823287850
   PubMed Web of Science ®Google Scholar
• LeeYJParkIKParkMSActivating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinomaJ Cancer Res Clin Oncol2009135121647165419517135
   PubMed Web of Science ®Google Scholar
• D’AngeloSPJanjigianYYAhyeNDistinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinibJ Thorac Oncol20127121815182223154553
   PubMed Web of Science ®Google Scholar
• GovindanRDingLGriffithMGenomic landscape of non-small cell lung cancer in smokers and never-smokersCell201215061121113422980976
   PubMed Web of Science ®Google Scholar
• LiMZhangQLiuLThe different clinical significance of EGFR mutations in exon 19 and 21 in non-small cell lung cancer patients of ChinaNeoplasma2011581748121067269
   PubMed Web of Science ®Google Scholar
• ZouJBellaAEChenZFrequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: implication of cancer biological behaviour regulated by EGFR mutationJ Int Med Res20144251110111725239875
   PubMed Web of Science ®Google Scholar
• LeHWangXZhaYPeripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleuraOncol Lett20171467931794029250182
   PubMed Web of Science ®Google Scholar
• LinMWWuCTShihJYChangYLYangPCClinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimensionJ Surg Oncol201411029910624788590
   PubMed Web of Science ®Google Scholar
• TravisWDBrambillaERami-PortaRVisceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancerJ Thorac Oncol20083121384139019057261
   PubMed Web of Science ®Google Scholar